Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration
暂无分享,去创建一个
M. Dowsett | M. Jarman | I. Smith | S. Johnston | N. Sacks | S. Ebbs | B. Haynes
[1] M. Dowsett,et al. Towards a molecular basis for tamoxifen resistance in breast cancer. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] W. McGuire,et al. Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Osborne,et al. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. , 1991, Journal of the National Cancer Institute.
[4] G. Leclercq,et al. Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent. , 1989, Journal of medicinal chemistry.
[5] A. Harris,et al. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma. , 1982, Cancer research.
[6] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[7] V. Jordan,et al. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer. , 1990, European journal of cancer.
[8] M. Nadji,et al. Receptors reconsidered: a 20-year perspective. , 1982, Recent progress in hormone research.